-+ 0.00%
-+ 0.00%
-+ 0.00%

Immuneering Q1 EPS $(0.21) Beats $(0.26) Estimate

Benzinga·05/15/2026 11:38:49
Listen to the news
Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 50 percent increase over losses of $(0.42) per share from the same period last year.